Tema Cardiovascular and Metabolics ETF (HRTS) Holdings $33.20 +0.57 (+1.75%) (As of 11/1/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestTrends Top 46 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1AMGNAmgen$319.22-0.3%7.92%20,7592LLYEli Lilly and Company$818.93-1.3%5.49%5,0333ALNYAlnylam Pharmaceuticals$273.91+2.7%5.29%15,3954VRTXVertex Pharmaceuticals$471.12-1.0%4.97%8,7615Chugai Pharmaceutical Co., Ltd.N/A3.93%64,7286Novo Nordisk A/SN/A3.75%27,891 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 7CRNXCrinetics Pharmaceuticals$56.69+1.3%3.66%53,8348BBIOBridgeBio Pharma$25.48+8.8%3.63%122,7919AstraZeneca PLCN/A3.46%19,13510CYTKCytokinetics$51.82+1.6%3.16%50,86811MDTMedtronic$90.07+0.9%2.84%26,05412REGNRegeneron Pharmaceuticals$843.60+0.6%2.73%2,43613MREOMereo BioPharma Group$4.28+1.7%2.66%524,03114MASIMasimo$144.22+0.1%2.51%14,72815BSXBoston Scientific$83.62-0.5%2.50%24,52616IONSIonis Pharmaceuticals$38.76+1.0%2.50%52,09617GPCRStructure Therapeutics$41.140.0%2.24%47,59018RAREUltragenyx Pharmaceutical$50.992.15%33,67519MIRMMirum Pharmaceuticals$40.40+5.0%2.12%45,04520MLYSMineralys Therapeutics$13.45+0.5%2.10%124,50221ASNDAscendis Pharma A/S$125.28+2.0%2.05%13,41222RCKTRocket Pharmaceuticals$16.98+2.0%2.04%97,66623KROSKeros Therapeutics$59.94+3.3%2.03%28,00224PODDInsulet$235.61+1.8%2.01%7,17525DXCMDexCom$70.35-0.2%1.98%22,75826EWEdwards Lifesciences$67.54+0.8%1.94%23,21627ARWRArrowhead Pharmaceuticals$19.49+1.4%1.59%66,02528NTLAIntellia Therapeutics$14.81+4.1%1.59%88,01529Zealand Pharma A/SN/A1.36%9,46030AKROAkero Therapeutics$32.33+4.9%1.32%34,51331WSTWest Pharmaceutical Services$316.50+2.8%1.31%3,40132Novartis AGN/A1.29%9,72133SLNSilence Therapeutics$17.68+2.2%1.13%52,13234MDGLMadrigal Pharmaceuticals$319.58+23.2%1.02%3,87535EWTXEdgewise Therapeutics$34.00+1.3%0.98%23,54736SLNOSoleno Therapeutics$55.86+1.5%0.96%14,14737NARIInari Medical$48.74+0.7%0.94%15,87838VKTXViking Therapeutics$72.88+0.5%0.94%10,65539First American Treasury Obligs XN/A0.74%614,63940TERNTerns Pharmaceuticals$6.94+1.2%0.71%85,544Invest in the AI Boom: Top 5 Stocks to Watch (Ad)By now, you're well aware of the artificial intelligence boom. Big Tech has been investing billions of dollars into AI, and the market is projected to grow exponentially. According to several recent reports, the AI market, currently valued at around $100 billion, could grow twenty-fold by 2030 to more than $2 trillion. This explosive growth means it's time to consider these top AI stocks. [Click Here to Automatically Download Your Free eBook Now]41VERVVerve Therapeutics$5.93+3.5%0.69%95,80142Gubra A/SN/A0.60%7,59043CRBPCorbus Pharmaceuticals$16.92+6.0%0.48%24,52544TNYATenaya Therapeutics$1.94+1.0%0.40%170,50145RANIRani Therapeutics$2.31+0.9%0.30%105,60446DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A-0.04%523,440,218 Geographic ExposureUnited States82.9%Denmark5.2%Japan3.9%United Kingdom3.4%Ireland2.9%Switzerland1.3%Currency ExposureUSD85.8%DKK5.8%JPY3.9%GBP3.4%CHF1.3%Sector ExposureHealth Care73.2%Industry ExposureBiotechnology56.7%Health Care Equipment & Supplies15.3%Pharmaceuticals1.3%SubIndustry ExposureBiotechnology53.9%Health Care Equipment14.0%Pharmaceuticals1.3%Health Care Supplies1.3%Coupon Exposure4-60.8%Maturity Exposure15-200.8% Related Companies and Tools Related Companies iShares ESG Advanced MSCI EM ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies REX AI Equity Premium Income ETF Portfolio Companies Fidelity Disruptors ETF Portfolio Companies Tradr 2X Short Innovation Daily ETF Portfolio Companies CrossingBridge Pre-Merger SPAC ETF Portfolio Companies Siren Nasdaq NexGen Economy ETF Portfolio Companies Fidelity Disruptive Automation ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
